The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins
Covid-19 has emerged as a global threat that has claimed millions of lives until now. Haematological...
We described three COVID-19-infected patients with profound immune thrombocytopenia causing...
Background: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease...
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-1...
COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such a...
Hematologic changes are common in coronavirus infections, including lymphopenia and thrombocytopenia...
none5noHere, we describe three cases of immune-mediated thrombocytopenia during the severe acute res...
Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected by SAR...
The novel coronavirus disease (COVID-19) is not only a disease that affects the respiratory system b...
Since the global coronavirus disease 2019 (COVID-19) pandemic began, findings indicate that severe a...
Thrombocytopenia is a risk factor for increased morbidity and mortality in patients with the new sev...
The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the be...
Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has been reported as a...
BACKGROUND: Despites its benefits, as one of COVID-19 principal treatments, anticoagulant raises a s...
SARS CoV-2 infection is associated with various hematological manifestations, including leucopenia, ...
Covid-19 has emerged as a global threat that has claimed millions of lives until now. Haematological...
We described three COVID-19-infected patients with profound immune thrombocytopenia causing...
Background: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease...
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-1...
COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such a...
Hematologic changes are common in coronavirus infections, including lymphopenia and thrombocytopenia...
none5noHere, we describe three cases of immune-mediated thrombocytopenia during the severe acute res...
Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected by SAR...
The novel coronavirus disease (COVID-19) is not only a disease that affects the respiratory system b...
Since the global coronavirus disease 2019 (COVID-19) pandemic began, findings indicate that severe a...
Thrombocytopenia is a risk factor for increased morbidity and mortality in patients with the new sev...
The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the be...
Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has been reported as a...
BACKGROUND: Despites its benefits, as one of COVID-19 principal treatments, anticoagulant raises a s...
SARS CoV-2 infection is associated with various hematological manifestations, including leucopenia, ...
Covid-19 has emerged as a global threat that has claimed millions of lives until now. Haematological...
We described three COVID-19-infected patients with profound immune thrombocytopenia causing...
Background: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease...